You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 56 No. 5, May 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (294)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Nutritional and Metabolic Disorders
 •Lipids and Lipid Disorders
 •Bipolar Disorder
 •Alert me on articles by topic

Omega 3 Fatty Acids in Bipolar Disorder

A Preliminary Double-blind, Placebo-Controlled Trial

Andrew L. Stoll, MD; W. Emanuel Severus, MD, PhD; Marlene P. Freeman, MD; Stephanie Rueter; Holly A. Zboyan; Eli Diamond; Kimberly K. Cress, MD; Lauren B. Marangell, MD

Arch Gen Psychiatry. 1999;56:407-412.

Background  {omega}3 Fatty acids may inhibit neuronal signal transduction pathways in a manner similar to that of lithium carbonate and valproate, 2 effective treatments for bipolar disorder. The present study was performed to examine whether {omega}3 fatty acids also exhibit mood-stabilizing properties in bipolar disorder.

Methods  A 4-month, double-blind, placebo-controlled study, comparing {omega}3 fatty acids (9.6 g/d) vs placebo (olive oil), in addition to usual treatment, in 30 patients with bipolar disorder.

Results  A Kaplan-Meier survival analysis of the cohort found that the {omega}3 fatty acid patient group had a significantly longer period of remission than the placebo group (P=.002; Mantel-Cox). In addition, for nearly every other outcome measure, the {omega}3 fatty acid group performed better than the placebo group.

Conclusion  {omega}3 Fatty acids were well tolerated and improved the short-term course of illness in this preliminary study of patients with bipolar disorder.


From the Psychopharmacology Unit, Division of Psychiatry, Brigham and Women's Hospital (Drs Stoll, Severus, and Freeman, Ms Rueter, and Mr Diamond), and Department of Psychiatry, Harvard Medical School (Drs Stoll and Freeman), Boston, Mass; Free University of Berlin, Berlin, Germany (Dr Severus); and Department of Psychiatry, Baylor College of Medicine, Houston, Tex (Ms Zboyan and Drs Cress and Marangell). Dr Stoll is now with the Psychopharmacology Research Laboratory, McLean Hospital, Belmont, Mass, and continues with the Department of Psychiatry, Harvard Medical School.


RELATED ARTICLES

Fish Oils and Bipolar Disorder: A Promising but Untested Treatment
Joseph R. Calabrese, Daniel J. Rapport, and Melvin D. Shelton
Arch Gen Psychiatry. 1999;56(5):413-414.
EXTRACT | FULL TEXT  

In Reply
Andrew L. Stoll and Lauren B. Marangell
Arch Gen Psychiatry. 1999;56(5):415-416.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Importance of the Omega-6/Omega-3 Fatty Acid Ratio in Cardiovascular Disease and Other Chronic Diseases
Simopoulos
Exp. Biol. Med. 2008;233:674-688.
ABSTRACT | FULL TEXT  

Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention: effect of dietary n-3 fatty acids containing phospholipids
Vaisman et al.
Am. J. Clin. Nutr. 2008;87:1170-1180.
ABSTRACT | FULL TEXT  

Niko Tinbergen's life and work: a new approach to biology
Mysterud
Social Science Information 2007;46:543-553.
ABSTRACT  

Preliminary in vivo evidence of increased N-acetyl-aspartate following eicosapentanoic acid treatment in patients with bipolar disorder
Frangou et al.
J Psychopharmacol 2007;21:435-439.
ABSTRACT  

Themed Review: Anxiety/Depression: Lifestyle Medicine Approaches
Martinsen and Raglin
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2007;1:159-166.
ABSTRACT  

Docosahexaenoic acid synthesis from {alpha}-linolenic acid by rat brain is unaffected by dietary n-3 PUFA deprivationboxs
Igarashi et al.
J. Lipid Res. 2007;48:1150-1158.
ABSTRACT | FULL TEXT  

References
APPI Online CME 2007;2007:2-2.
FULL TEXT  

Do omega-3 fatty acids help in depression?
DTB 2007;45:9-12.
ABSTRACT | FULL TEXT  

Treatment-Resistant Bipolar Disorder
Gitlin
Focus 2007;5:49-63.
ABSTRACT | FULL TEXT  

Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials
Appleton et al.
Am. J. Clin. Nutr. 2006;84:1308-1316.
ABSTRACT | FULL TEXT  

Depression and cardiovascular mortality: a role for n-3 fatty acids?
Kamphuis et al.
Am. J. Clin. Nutr. 2006;84:1513-1517.
ABSTRACT | FULL TEXT  

Current Clinical Applications of {Omega}-6 and {Omega}-3 Fatty Acids
Lee et al.
Nutr Clin Pract 2006;21:323-341.
ABSTRACT | FULL TEXT  

Omega-3 Fatty Acids and Mood Disorders
Parker et al.
Am. J. Psychiatry 2006;163:969-978.
ABSTRACT | FULL TEXT  

Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity
Hibbeln et al.
Am. J. Clin. Nutr. 2006;83:S1483-1493S.
ABSTRACT | FULL TEXT  

Complementary medicines in psychiatry: Review of effectiveness and safety
WERNEKE et al.
Br. J. Psychiatry 2006;188:109-121.
ABSTRACT | FULL TEXT  

One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats
DeMar et al.
J. Lipid Res. 2006;47:172-180.
ABSTRACT | FULL TEXT  

Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study
FRANGOU et al.
Br. J. Psychiatry 2006;188:46-50.
ABSTRACT | FULL TEXT  

Metabolism, lifestyle and bipolar affective disorder
Morriss and Mohammed
J Psychopharmacol 2005;19:94-101.
ABSTRACT  

Essential fatty acids and mental health
HALLAHAN and GARLAND
Br. J. Psychiatry 2005;186:275-277.
FULL TEXT  

Integrative Oncology: Complementary Therapies for Pain, Anxiety, and Mood Disturbance
Deng and Cassileth
CA Cancer J Clin 2005;55:109-116.
ABSTRACT | FULL TEXT  

Practical Applications of Fish Oil ({Omega}-3 Fatty Acids) in Primary Care
Oh
J Am Board Fam Med 2005;18:28-36.
ABSTRACT | FULL TEXT  

Omega-3 Fatty Acid Treatment and T2 Whole Brain Relaxation Times in Bipolar Disorder
Hirashima et al.
Am. J. Psychiatry 2004;161:1922-1924.
ABSTRACT | FULL TEXT  

Pharmacotherapy of Bipolar Disorder in Old Age: Review and Recommendations
Young et al.
AJGP 2004;12:342-357.
ABSTRACT | FULL TEXT  

Bipolar Disorder
Belmaker
NEJM 2004;351:476-486.
FULL TEXT  

Cross-national differences in diet, the outcome of schizophrenia and the prevalence of depression: you are (associated with) what you eat
McIntosh and Lawrie
Br. J. Psychiatry 2004;184:381-382.
FULL TEXT  

Is Low Dietary Intake of Omega-3 Fatty Acids Associated With Depression?
Hakkarainen et al.
Am. J. Psychiatry 2004;161:567-569.
ABSTRACT | FULL TEXT  

Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials
Fergusson et al.
BMJ 2004;328:432.
ABSTRACT | FULL TEXT  

Cross-National Comparisons of Seafood Consumption and Rates of Bipolar Disorders
Noaghiul and Hibbeln
Am. J. Psychiatry 2003;160:2222-2227.
ABSTRACT | FULL TEXT  

Increased Coronary Events in Depressed Cardiovascular Patients: 5-HT2A Receptor as Missing Link?
Schins et al.
Psychosom. Med. 2003;65:729-737.
ABSTRACT | FULL TEXT  

Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study
Tiemeier et al.
Am. J. Clin. Nutr. 2003;78:40-46.
ABSTRACT | FULL TEXT  

A Double-Blind, Placebo-Controlled Study of the Omega-3 Fatty Acid Docosahexaenoic Acid in the Treatment of Major Depression
Marangell et al.
Am. J. Psychiatry 2003;160:996-998.
ABSTRACT | FULL TEXT  

Practice Guideline for the Treatment of Patients With Bipolar Disorder (Revision)
Hirschfeld et al.
Focus 2003;1:64-110.
FULL TEXT  

Omega-3 Fatty Acid Treatment of Women With Borderline Personality Disorder: A Double-Blind, Placebo-Controlled Pilot Study
Zanarini and Frankenburg
Am. J. Psychiatry 2003;160:167-169.
ABSTRACT | FULL TEXT  

Omega-3 Fatty Acids in Inflammation and Autoimmune Diseases
Simopoulos
J. Am. Coll. Nutr. 2002;21:495-505.
ABSTRACT | FULL TEXT  

A Dose-Ranging Study of the Effects of Ethyl-Eicosapentaenoate in Patients With Ongoing Depression Despite Apparently Adequate Treatment With Standard Drugs
Peet and Horrobin
Arch Gen Psychiatry 2002;59:913-919.
ABSTRACT | FULL TEXT  

Do Lithium and Anticonvulsants Target the Brain Arachidonic Acid Cascade in Bipolar Disorder?
Rapoport and Bosetti
Arch Gen Psychiatry 2002;59:592-596.
ABSTRACT | FULL TEXT  

Essential fatty acids: theoretical aspects and treatment implications for schizophrenia and depression
Peet
Adv. Psychiatr. Treat. 2002;8:223-229.
FULL TEXT  

Addition of Omega-3 Fatty Acid to Maintenance Medication Treatment for Recurrent Unipolar Depressive Disorder
Nemets et al.
Am. J. Psychiatry 2002;159:477-479.
ABSTRACT | FULL TEXT  

Clinical nutrition: 3. The fuzzy boundary between nutrition and psychopharmacology
Young
CMAJ 2002;166:205-209.
FULL TEXT  

Eicosapentaenoic Acid in Treatment-Resistant Depression
Puri et al.
Arch Gen Psychiatry 2002;59:91-92.
FULL TEXT  

Non-Herbal Nutritional Supplements--The Next Wave: A Comprehensive Review of Risks and Benefits for the C-L Psychiatrist
Crone et al.
Psychosomatics 2001;42:285-299.
ABSTRACT | FULL TEXT  

The electrophysiological basis for the antiarrhythmic actions of polyunsaturated fatty acids
Leaf
Eur Heart J Suppl 2001;3:D98-D105.
ABSTRACT  

The Stanley Foundation Bipolar Network: 1. Rationale and methods
POST et al.
Br. J. Psychiatry 2001;178 :s169-s176.
ABSTRACT | FULL TEXT  

Delivery and turnover of plasma-derived essential PUFAs in mammalian brain
Rapoport et al.
J. Lipid Res. 2001;42:678-685.
ABSTRACT | FULL TEXT  

Fish Consumption, Depression, and Suicidality in a General Population
Tanskanen et al.
Arch Gen Psychiatry 2001;58:512-513.
FULL TEXT  

Fish Consumption and Depressive Symptoms in the General Population in Finland
Tanskanen et al.
Psychiatr. Serv. 2001;52:529-531.
ABSTRACT | FULL TEXT  

Lack of Seasonal Mood Change in Icelanders
COTT and HIBBELN
Am. J. Psychiatry 2001;158:328-328.
FULL TEXT  

Treatment of bipolar affective disorder
Young et al.
BMJ 2000;321:1302-1303.
FULL TEXT  

Effects of polyunsaturated fatty acids on psychiatric disorders
Su et al.
Am. J. Clin. Nutr. 2000;72:1241-1241.
FULL TEXT  

Phospholipid Spectrum Disorder in Psychiatry: Edited by Malcolm Peet, Iain Glen and David F. Horrobin
Corrigan
Br. J. Psychiatry 2000;177 :191a-191a.
FULL TEXT  

The Effects of Olive Oil on {omega}3 Fatty Acids and Mood Disorders
Puri et al.
Arch Gen Psychiatry 2000;57:715-715.
FULL TEXT  

Are {omega}3 Fatty Acids Beneficial in Depression but Not Mania?
Su et al.
Arch Gen Psychiatry 2000;57:716-717.
FULL TEXT  

Plasma total cholesterol concentrations do not predict cerebrospinal fluid neurotransmitter metabolites: implications for the biophysical role of highly unsaturated fatty acids
Hibbeln et al.
Am. J. Clin. Nutr. 2000;71:331S-338S.
ABSTRACT | FULL TEXT  

A Natural Thymoleptic?
JWatch Psychiatry 1999;1999:4-4.
FULL TEXT  

Fish Oils and Bipolar Disorder: A Promising but Untested Treatment
Calabrese et al.
Arch Gen Psychiatry 1999;56:413-414.
FULL TEXT  

Protein Kinase Inhibition by omega -3 Fatty Acids
Mirnikjoo et al.
J. Biol. Chem. 2001;276:10888-10896.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.